Welcome to MyCLL
This website is intended only for UK patients who have been prescribed Calquence (acalabrutinib). This website has been produced and funded by AstraZeneca.
Please select the relevant option:
Your medicine is an oral targeted treatment that helps fight CLL cancer cells, offering an alternative to traditional chemotherapy.1,2 For more information, visit About Calquence.
If you have taken more Calquence than instructed, see a doctor or go to the nearest hospital immediately. Take the tablets and patient information leaflet with you.1,2 For more information on how to take your medicine, visit our About Calquence page.
Calquence is a targeted cancer treatment that blocks a signal inside CLL cells, called bruton tyrosine kinase or BTK. This signal normally tells CLL cells to survive and grow. By blocking BTK, Calquence switches off these signals. This can slow down the growth and build-up of CLL cells in the lymph nodes (small glands in your body).1
Venetoclax is another targeted treatment that blocks a protein in CLL cells called BCL-2. This protein helps CLL cells stay alive when they should naturally break down. By blocking BCL-2, venetoclax makes it easier for CLL cells to die.3
Using both medicines together helps stop CLL cells from growing in two different ways. These medicines are both tablets you take by mouth. They are targeted treatments and not chemotherapy. For more information on these medicines, read the packaging leaflets in each box and speak to your healthcare team.
Always take Calquence exactly as your doctor has told you. Check with your doctor, pharmacist or nurse if you are not sure.
Most people continue treatment until the medicine stops controlling the CLL or side effects outweigh the benefits. Some patients remain on Calquence for several years with regular monitoring. If you are prescribed acalabrutinib in combination with venetoclax, this will be given for a maximum of 14 treatment cycles (each cycle is 28 days).1 Your doctor will review your response at every appointment and guide any future changes.
This medicinal product does not require any special storage conditions.1 For more information, please read the patient information leaflet.
When you start venetoclax, your doctor will slowly increase your dose to help your body adjust. This is to lower the chance of a problem called tumour lysis syndrome (TLS), which can happen when cancer cells die quickly.3 To reduce this risk, you may need extra blood tests and to drink plenty of fluids. Your team will tell you exactly what to do and when to come in. If you feel unwell at any time during the ramp up of venetoclax, contact your healthcare team straight away.
This is not a full list and you may have other side effects. Please read the package leaflets in each box and talk to your healthcare team. In some cases, your doctor may need to stop your treatment. Some side effects require urgent care. See the patient information leaflet and About Calquence page for more information.
Colds, throat, chest infections
Stomach upset
Urinary tract infections (UTIs)
Bruising and bleeding
Feeling very tired (fatigue)
Muscle and joint pain
Headache
Rash
Contact your healthcare team about any side effects and new or worsening symptoms. If you are unsure about how to take your treatment, ask your healthcare team as they will support you with any questions you may have.
You will have regular blood tests and check‑ups to check how you are doing and how well this medicine is working for you.
If your symptoms are improving since taking Calquence, it suggests your medication may be working for you. You should continue taking your medication until you are advised otherwise by your healthcare professional.1,2
Managing chronic lymphocytic leukaemia (CLL) is a team effort. You’ll be supported by a team of doctors, nurses and other specialists who will help you to manage your treatment. You could use an appointment checklist to help you make the most of the time you have with your healthcare team. Tell your doctor, nurse, or pharmacist about all medicines you are taking, have recently taken or might take including vitamins and herbal remedies. Talk to your healthcare team about any new side effects or worsening symptoms. It can also help to talk about how you are feeling day-to-day. This includes any changes to your wellbeing or quality of life.
Tell your doctor, nurse, or pharmacist about all medicines you are taking, have recently taken or might take. This includes vitamins and herbal remedies. Some medicines (like certain antibiotics, antifungals, or St John’s wort) can change how your treatment works.1 Calquence may make you bleed more easily.2 Tell your doctor if you take medicines that can increase bleeding. This includes medicines like aspirin, clopidogrel, or blood thinners. Please refer to the patient information leaflet for more information.
Talk to your doctor before taking Calquence if you have recently had surgery or dental work or are about to. Your doctor may tell you to stop taking Calquence for a short time.1
Other supportive sources include CLL Support, Blood Cancer UK, Macmillan Cancer Support, Leukaemia Care, and the NHS website. You can access the patient information leaflet for more information on your medicine here. Your clinical nurse specialist can connect you with peer-support services to help you live well with CLL.5
BCL-2, B-cell lymphoma 2; BTK, bruton tyrosine kinase; CLL, chronic lymphocytic leukaemia
GB-82674 | November 2026
Welcome to MyCLL
This website is intended only for UK patients who have been prescribed Calquence (acalabrutinib). This website has been produced and funded by AstraZeneca.
Please select the relevant option: